Roche to buy biopharmaceutical firm 89bio in $3.5bn deal

Written on 18/09/2025

Karen Leigh, Bloomberg

The acquisition will bolster the Swiss pharmaceutical giant’s pipeline of treatments for cardiovascular, renal, and metabolic diseases.